AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024

InvestorPlace - Stock Market News, Stock Advice & Trading Tips

AGRX stock results show that Agile Therapeutics missed analyst estimates for earnings per share but beat on revenue for the first quarter of 2024.

The post AGRX Stock Earnings: Agile Therapeutics Misses EPS, Beats Revenue for Q1 2024 appeared first on InvestorPlace.

More From InvestorPlace

• The #1 AI Investment Might Be This Company You’ve Never Heard Of
• Musk’s “Project Omega” May Be Set to Mint New Millionaires. Here’s How to Get In.
• It doesn’t matter if you have $500 or $5 million. Do this now.